Louis Kayitalire, M.D.

Chief Medical Officer

Dr. Kayitalire brings over 20 years of experience in oncology and immuno-oncology in clinical research in Europe (12 years) and in the US(13 years). He completed his medical training at Butare University, Rwanda, and later as Assistant Professor in Oncology at the Paris XI University of France. After 7 years treating patients with cancer at Gustave Roussy Institute, a major academic cancer center in Paris-France, he moved into research of new therapies for pharmaceutical companies with increasing responsibilities in big, mid-size or small biotech such as Eli Lilly, Bristol Myers Squibb, Cephalon, Celgene and F-star therapeutics. He is an active member of the American Society of Clinical Oncology (ASCO) , the American Association for Cancer Research (AACR) and the Society for Immunotherapy of Cancer (SITC).